Landovitz, R. J., Hanscom, B. S., Clement, M. E., HPTN 083 Study Team (2023). Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. The lancet. HIV, 10(12), e767–e778. https://doi.org/10.1016/S2352-3018(23)00261-8
